KR20220074809A - UV block for animal with skin and fur comprising mixture of plant extract as effective component - Google Patents
UV block for animal with skin and fur comprising mixture of plant extract as effective component Download PDFInfo
- Publication number
- KR20220074809A KR20220074809A KR1020210167486A KR20210167486A KR20220074809A KR 20220074809 A KR20220074809 A KR 20220074809A KR 1020210167486 A KR1020210167486 A KR 1020210167486A KR 20210167486 A KR20210167486 A KR 20210167486A KR 20220074809 A KR20220074809 A KR 20220074809A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- animal
- mixture
- quasi
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000000419 plant extract Substances 0.000 title description 5
- 239000000284 extract Substances 0.000 claims abstract description 72
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 241000611223 Selaginella lepidophylla Species 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 8
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 6
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims abstract description 6
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 244000060011 Cocos nucifera Species 0.000 claims description 9
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- -1 Shea Butter Substances 0.000 claims description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 230000004224 protection Effects 0.000 claims description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- 244000044822 Simmondsia californica Species 0.000 claims description 4
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 4
- 229940094944 saccharide isomerate Drugs 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- 240000003538 Chamaemelum nobile Species 0.000 claims description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 3
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002670 Fructan Polymers 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 3
- 240000007926 Ocimum gratissimum Species 0.000 claims description 3
- 240000007817 Olea europaea Species 0.000 claims description 3
- WXAYTPABEADAAB-UHFFFAOYSA-N Oxyphencyclimine hydrochloride Chemical compound Cl.CN1CCCN=C1COC(=O)C(O)(C=1C=CC=CC=1)C1CCCCC1 WXAYTPABEADAAB-UHFFFAOYSA-N 0.000 claims description 3
- 244000025272 Persea americana Species 0.000 claims description 3
- 235000008673 Persea americana Nutrition 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 240000005481 Salvia hispanica Species 0.000 claims description 3
- 235000001498 Salvia hispanica Nutrition 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 3
- 229940069638 aloe vera leaf extract Drugs 0.000 claims description 3
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 claims description 3
- 235000021302 avocado oil Nutrition 0.000 claims description 3
- 239000008163 avocado oil Substances 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 235000007215 black sesame Nutrition 0.000 claims description 3
- 229940107161 cholesterol Drugs 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 3
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 3
- 239000011666 cyanocobalamin Substances 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- 229940113120 dipropylene glycol Drugs 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims description 3
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 3
- 229940051810 licorice root extract Drugs 0.000 claims description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 229940101267 panthenol Drugs 0.000 claims description 3
- 235000020957 pantothenol Nutrition 0.000 claims description 3
- 239000011619 pantothenol Substances 0.000 claims description 3
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims description 3
- 229940033329 phytosphingosine Drugs 0.000 claims description 3
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 claims description 3
- 229940061570 polyglyceryl-10 stearate Drugs 0.000 claims description 3
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 3
- 235000008160 pyridoxine Nutrition 0.000 claims description 3
- 239000011677 pyridoxine Substances 0.000 claims description 3
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 claims description 3
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 235000011083 sodium citrates Nutrition 0.000 claims description 3
- 229940032094 squalane Drugs 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 3
- 229960001295 tocopherol Drugs 0.000 claims description 3
- 229930003799 tocopherol Natural products 0.000 claims description 3
- 235000010384 tocopherol Nutrition 0.000 claims description 3
- 239000011732 tocopherol Substances 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 229940011671 vitamin b6 Drugs 0.000 claims description 3
- 229940119569 wormwood extract Drugs 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- 235000005881 Calendula officinalis Nutrition 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 2
- 240000000785 Tagetes erecta Species 0.000 claims description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2
- 235000013734 beta-carotene Nutrition 0.000 claims description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2
- 239000011648 beta-carotene Substances 0.000 claims description 2
- 229960002747 betacarotene Drugs 0.000 claims description 2
- 229940119170 jojoba wax Drugs 0.000 claims description 2
- 229940096894 lentil seed extract Drugs 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2
- 206010030113 Oedema Diseases 0.000 abstract description 18
- 230000006750 UV protection Effects 0.000 abstract description 6
- 231100000344 non-irritating Toxicity 0.000 abstract description 4
- 206010015150 Erythema Diseases 0.000 description 22
- 238000012360 testing method Methods 0.000 description 20
- 231100000321 erythema Toxicity 0.000 description 18
- 210000003491 skin Anatomy 0.000 description 18
- 230000000475 sunscreen effect Effects 0.000 description 17
- 239000000516 sunscreening agent Substances 0.000 description 17
- 238000005299 abrasion Methods 0.000 description 14
- 239000000126 substance Substances 0.000 description 13
- 206010040880 Skin irritation Diseases 0.000 description 11
- 239000003595 mist Substances 0.000 description 11
- 231100000475 skin irritation Toxicity 0.000 description 11
- 230000036556 skin irritation Effects 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 241000282472 Canis lupus familiaris Species 0.000 description 6
- 206010040914 Skin reaction Diseases 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- 230000035483 skin reaction Effects 0.000 description 4
- 231100000430 skin reaction Toxicity 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 231100000159 OECD 404 Acute Dermal Irritation/Corrosion Toxicity 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- FHYNZKLNCPUNEU-UHFFFAOYSA-N 4-[(3,4-dihydroxyphenyl)methyl]-3-[(4-hydroxyphenyl)methyl]oxolan-2-one Chemical compound C1=CC(O)=CC=C1CC1C(=O)OCC1CC1=CC=C(O)C(O)=C1 FHYNZKLNCPUNEU-UHFFFAOYSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000544656 Cedrus atlantica Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- RODZIAKMFCIGPL-UHFFFAOYSA-N P.I.I Chemical compound P.I.I RODZIAKMFCIGPL-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000010627 cedar oil Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Abstract
본 발명은 로즈오브예리코(Selaginella lepidophylla) 추출물, 브로콜리 추출물 및 아이슬란드이끼 추출물의 혼합물을 유효성분으로 포함하는 피모동물용 자외선 차단용 의약외품에 관한 것으로, 상기 유효성분이 자외선을 차단할뿐만 아니라, 피부 홍반, 가피 및 부종과 같이 피부를 자극하지 않는 것이다.The present invention relates to a quasi-drug for UV protection for coat animals comprising a mixture of Rose of Jericho ( Selaginella lepidophylla ) extract, broccoli extract, and Icelandic moss extract as an active ingredient. and non-irritating to the skin such as edema.
Description
본 발명은 식물 추출물의 혼합물을 유효성분으로 포함하는 피모동물용 자외선 차단제에 관한 것이다.The present invention relates to a sunscreen for coat animals comprising a mixture of plant extracts as an active ingredient.
생체의 외부환경에 대한 첫번째 장벽인 피부 위생은 반려동물의 건강에 있어서 매우 중요하다. 피모동물의 피부는 사람보다 피부가 약하고 피부의 성질도 다르기 때문에 인간에게 적합한 성분이라도 피모동물에게는 적합하지 않은 경우가 종종 있으며, 특히 반려견 또는 반려묘의 미용을 위해 털을 제거하는 경우가 종종 발생하게 된다. 이와 같이 피모 동물의 털을 제거하는 경우, 직접적으로 털이 제거된 피부를 햇빛에 노출시킬 경우, 각종 피부질환을 유발할 수 있다. 동물의 경우, 피부 미백을 위한 자외선 차단제가 필요한 것이라기보다는 피부질환의 예방 차원에서 자외선 차단제는 필요하다. 일례로, 개(반려견)의 경우 피부의 표피는 3 ~ 5층으로 이루어져 사람의 피부보다 약하고, 피부의 성질도 사람의 경우에는 약산성인데 비하여 개의 경우에는 약알칼리성의 성질을 가지고 있다.Skin hygiene, which is the first barrier to the external environment of the living body, is very important for the health of companion animals. Because the skin of fur animals is weaker than humans and the nature of the skin is different, even if the ingredients are suitable for humans, they are often not suitable for coat animals. . In the case of removing the hair of the fur animal as described above, when the skin from which the hair is directly removed is exposed to sunlight, various skin diseases may be caused. In the case of animals, sunscreens are needed for the prevention of skin diseases rather than for skin whitening. For example, in the case of dogs (dogs), the epidermis of the skin consists of 3 to 5 layers, which is weaker than human skin, and the nature of the skin is weakly acidic in the case of humans, whereas in the case of dogs, it has weak alkaline properties.
이와 같이 인간의 기쁨을 위해 털을 제거하는 등의 이유로, 반려견이나 반려묘의 피부가 직접적으로 자외선에 노출되는 횟수가 증가하게 되는 문제점이 발생하고 있다. 하지만 아직까지는 반려동물 등에 적용되고 있는 피부 보호제는 보습제 또는 세정제 수준에 그치고 있는 실정이다. As such, for reasons such as removing hair for human pleasure, there is a problem in that the number of times the skin of a dog or cat is directly exposed to ultraviolet rays increases. However, skin protectants applied to companion animals and the like are still at the level of moisturizing agents or cleaning agents.
한편, 한국공개특허 제2020-0065711호에 동물 피부질환 개선용 조성물이 개시되어 있고, 한국공개특허 제2020-0016691호에 애완동물의 피부질환 개선과 항균을 위해 사용되는 천연조성물이 개시되어 있으며, 한국등록특허 제2007762호에 돼지 방광 내피에서 추출한 세포외기질을 베이스로 하여, 천연물 복합추출물 및 해양심층암반 미네랄수를 혼합한 유효성분으로 하여 만든 반려동물 피모관리용 조성물이 개시되어 있으나, 아직까지는 본 발명의 식물 추출물의 혼합물을 유효성분으로 포함하는 피모동물용 자외선 차단제에 대해 개시된 바 없다.On the other hand, Korean Patent Publication No. 2020-0065711 discloses a composition for improving animal skin diseases, and Korean Patent Publication No. 2020-0016691 discloses a natural composition used for improving skin diseases and antibacterial in pets, Korean Patent No. 2007762 discloses a composition for managing the fur of companion animals, which is made with an active ingredient mixed with a natural product complex extract and deep sea bedrock mineral water based on the extracellular matrix extracted from the pig bladder endothelium. There is no disclosure of a sunscreen for coat animals comprising a mixture of a plant extract of the present invention as an active ingredient.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명은 식물 추출물의 혼합물을 유효성분으로 포함하는 피모동물용 자외선 차단제를 제공하고, 상기 유효성분이 자외선을 차단할뿐만 아니라, 피부 홍반, 가피 및 부종과 같이 피부를 자극하지 않는다는 것을 확인함으로써, 본 발명을 완성하였다.The present invention has been derived from the above needs, and the present invention provides a sunscreen for coat animals comprising a mixture of plant extracts as an active ingredient, and the active ingredient not only blocks UV rays, but also skin erythema, scab and edema By confirming that it does not irritate the skin, the present invention has been completed.
상기 목적을 달성하기 위하여, 본 발명은 로즈오브예리코(Selaginella lepidophylla) 추출물, 브로콜리 추출물 및 아이슬란드이끼 추출물의 혼합물을 유효성분으로 포함하는 피모동물의 피부 보호용 의약외품을 제공한다.In order to achieve the above object, the present invention provides a quasi-drug for protecting the skin of a coat animal comprising a mixture of Rose of Jericho ( Selaginella lepidophylla ) extract, broccoli extract, and Icelandic moss extract as an active ingredient.
본 발명은 식물 추출물의 혼합물을 유효성분으로 포함하는 피모동물용 자외선 차단제에 관한 것으로, 상기 유효성분인 로즈오브예리코(Selaginella lepidophylla) 추출물, 브로콜리 추출물 및 아이슬란드이끼 추출물의 혼합물이 자외선을 차단할 뿐만 아니라, 피부 홍반, 가피 및 부종이 발생하지 않는 효과가 있는 것이다.The present invention relates to a sunscreen for coat animals comprising a mixture of plant extracts as an active ingredient. It is effective in preventing skin erythema, crusting, and edema.
도 1은 본 발명의 모이스처 미스트를 찰과 부위에 투여한 후, 24~72시간 동안 홍반과 부종을 관찰한 결과이다.
도 2는 비교예의 펫용 썬스크린을 찰과 부위에 투여한 후, 24~72시간 동안 홍반과 부종을 관찰한 결과이다.
도 3은 본 발명의 로즈오브예리코(Selaginella lepidophylla) 추출물, 브로콜리 추출물 및 아이슬란드이끼 추출물의 혼합물의 자외선 B 차단 효과를 확인한 결과이다.1 is a result of observing erythema and edema for 24 to 72 hours after administering the moisture mist of the present invention to abrasion sites.
Figure 2 is the result of observing erythema and edema for 24 to 72 hours after administering the sunscreen for pets of Comparative Example to the abrasion site.
3 is a result confirming the UV B blocking effect of a mixture of Rose of Jericho ( Selaginella lepidophylla ) extract, broccoli extract, and Icelandic moss extract of the present invention.
본 발명은 로즈오브예리코(Selaginella lepidophylla) 추출물, 브로콜리 추출물 및 아이슬란드이끼 추출물의 혼합물을 유효성분으로 포함하는 피모동물의 피부 보호용 의약외품에 관한 것이다. The present invention relates to a quasi-drug for protecting the skin of a coat animal comprising a mixture of an extract of Rose of Jericho ( Selaginella lepidophylla ), an extract of broccoli and an Icelandic moss extract as an active ingredient.
상기 유효성분인 혼합물 이외에, 부틸렌글리콜, 사카라이드아이소머레이트, 아보카도 열매 추출물, 코코넛 야자 열매 추출물, 사철쑥 추출물, 프로판다이올, 폴리글리세릴-10라우레이트, 글리세린, 호호바씨 추출물, 멕시칸치아씨 추출물, 바질씨 추출물, 에스큘린타 렌즈콩씨 추출물, 포트마리골드 추출물, 알란토인, 캐모마일 꽃 오일, 아틀라스시다목부 오일, 1,2-헥산다이올, 코코넛 야자수, 프룩탄, 올리브 추출물, 세트롤, 디소듐이디티에이, 알로에베라 잎 추출물, 디프로필렌글리콜, 시어버터, 올리브 오일, 카프릴릭/카프릭트라이글리세라이드, 검은깨 추출물, 눈빛 승마 추출물, 도둑놈의지팡이 뿌리 추출물, 뽕나무 껍질 추출물, 스페인 감초 뿌리 추출물, 작약뿌리 추출물, 진흙버섯 추출물, 참당귀 뿌리, 폴리글리세릴-10스테아레이트, 하수오 뿌리 추출물, 황금 추출물, 스쿠알란, 판테놀, 소듐아스코빌포스페이트, 하이드로제네이티드 레시틴, 롱기폴렌, 소듐시트레이트, 시트릭애씨드, 아보카도 오일, 코코넛 야자 오리, 호호바씨 오일, 나이아신아마이드, 세라마이드엔피, 콜레스테롤, 바이오틴, 폴릭애씨드, 피리독신, 피토스핑고신, 사이아노코발아민, 토코페롤, 리놀레익애씨드, 피보플라빈, 베타-카로틴 및 티아민에이치씨엘을 더 포함할 수 있다.In addition to the active ingredient mixture, butylene glycol, saccharide isomerate, avocado fruit extract, coconut palm fruit extract, wormwood extract, propanediol, polyglyceryl-10 laurate, glycerin, jojoba seed extract, mexican chia seed extract, basil seed extract, esculinta lentil seed extract, port marigold extract, allantoin, chamomile flower oil, atlas cedar oil, 1,2-hexanediol, coconut palm tree, fructan, olive extract, setrol, diol Sodium EDT, Aloe Vera Leaf Extract, Dipropylene Glycol, Shea Butter, Olive Oil, Caprylic/Capric Triglyceride, Black Sesame Extract, Eye Horse Riding Extract, Thief's Wand Root Extract, Mulberry Bark Extract, Spanish Licorice Root Extract, Peony Root Extract, Mud Mushroom Extract, Angelica Root, Polyglyceryl-10 Stearate, Succulent Root Extract, Golden Extract, Squalane, Panthenol, Sodium Ascorbyl Phosphate, Hydrogenated Lecithin, Longi Pollen, Sodium Citrate , Citric Acid, Avocado Oil, Coconut Palm Duck, Jojoba Oil, Niacinamide, Ceramide NP, Cholesterol, Biotin, Folic Acid, Pyridoxine, Phytosphingosine, Cyanocobalamine, Tocopherol, Linoleic Acid, Fiboflavin , beta-carotene and thiamine HCL may be further included.
상기 각각의 추출물에 대한 추출용매는 물, C1~C4의 저급 알코올 또는 이들의 혼합물인 것이 바람직하며, 더 바람직하게는 물 추출물이지만 이에 한정하지 않는다. The extraction solvent for each of the extracts is preferably water, a C 1 to C 4 lower alcohol or a mixture thereof, and more preferably a water extract, but is not limited thereto.
각각의 천연물(식물)에 대하여, 추출용매를 첨가하여 추출하는 단계;Extracting each natural product (plant) by adding an extraction solvent;
2) 단계 1)의 추출물을 여과하는 단계; 및2) filtering the extract of step 1); and
3) 단계 2)의 여과한 추출물을 감압 농축하고 건조하여 추출물을 제조하는 단계.3) Concentrating the filtered extract of step 2) under reduced pressure and drying to prepare an extract.
상기 단계 1)에서 추출용매는 물, C1~C4의 저급 알코올 또는 이들의 혼합물인 것이 바람직하지만 이에 한정하지 않는다. In step 1), the extraction solvent is preferably water, C 1 to C 4 lower alcohol, or a mixture thereof, but is not limited thereto.
상기 제조방법에 있어서, 추출은 여과법, 열수 추출, 침지 추출, 환류 냉각 추출 및 초음파 추출 등의 당 업계에 공지된 모든 통상적인 방법을 이용할 수 있다. 상기 단계 3)의 감압농축은 진공 감압 농축기 또는 진공회전증발기를 이용하는 것이 바람직하나 이에 한정하지 않는다. 또한, 건조는 감압건조, 진공건조, 비등건조, 분무 건조 또는 동결 건조하는 것이 바람직하나 이에 한정하지 않는다.In the above preparation method, the extraction may use any conventional method known in the art, such as filtration, hot water extraction, immersion extraction, reflux cooling extraction, and ultrasonic extraction. It is preferable to use a vacuum vacuum concentrator or a vacuum rotary evaporator for the concentration under reduced pressure in step 3), but is not limited thereto. In addition, drying under reduced pressure, vacuum drying, boiling drying, spray drying or freeze drying is preferable, but is not limited thereto.
상기 피모동물의 피부 보호는 자외선 B에 대한 피부 보호인 것이 바람직하지만 이에 한정하지 않는다.Preferably, the skin protection of the coat animal is skin protection against ultraviolet B, but is not limited thereto.
상기 피모동물은 반려견 또는 반려묘인 것이 바람직하지만 이에 한정하지 않는다.The coat animal is preferably a dog or a cat, but is not limited thereto.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail using examples. These examples are only for illustrating the present invention in more detail, and it will be apparent to those of ordinary skill in the art that the scope of the present invention is not limited thereto.
실시예Example 1. 피모 동물용 자외선 차단제의 제조1. Manufacture of sunscreen for fur animals
88중량%의 로즈오브예리코(Selaginella lepidophylla) 추출물, 0.1중량%의 브로콜리 추출물 및 0.05중량%의 아이슬란드 이끼 추출물을 유효성분으로 포함하는 피모 동물용 자외선 차단제로서, 모이스처 미스트를 제조하였다. 상기 유효성분 이외에 부틸렌글리콜, 사카라이드아이소머레이트, 아보카도 열매 추출물, 코코넛 야자 열매 추출물, 사철쑥 추출물, 프로판다이올, 폴리글리세릴-10라우레이트, 글리세린, 호호바씨 추출물, 멕시칸치아씨 추출물, 바질씨 추출물, 에스큘린타 렌즈콩씨 추출물, 포트마리골드 추출물, 알란토인, 캐모마일 꽃 오일, 아틀라스시다목부 오일, 1,2-헥산다이올, 코코넛 야자수, 프룩탄, 올리브 추출물, 세트롤, 디소듐이디티에이, 알로에베라 잎 추출물, 디프로필렌글리콜, 시어버터, 올리브 오일, 카프릴릭/카프릭트라이글리세라이드, 검은깨 추출물, 눈빛 승마 추출물, 도둑놈의지팡이 뿌리 추출물, 뽕나무 껍질 추출물, 스페인 감초 뿌리 추출물, 작약뿌리 추출물, 진흙버섯 추출물, 참당귀 뿌리, 폴리글리세릴-10스테아레이트, 하수오 뿌리 추출물, 황금 추출물, 스쿠알란, 판테놀, 소듐아스코빌포스페이트, 하이드로제네이티드 레시틴, 롱기폴렌, 소듐시트레이트, 시트릭애씨드, 아보카도 오일, 코코넛 야자 오리, 호호바씨 오일, 나이아신아마이드, 세라마이드엔피, 콜레스테롤, 바이오틴, 폴릭애씨드, 피리독신, 피토스핑고신, 사이아노코발아민, 토코페롤, 리놀레익애씨드, 피보플라빈, 베타-카로틴 및 티아민에이치씨엘을 0.15중량%씩 포함하며, 증류수 2.7중량% 포함하도록 모이스처 미스트를 제조하였다. 상기 추출물들은 용매로 물을 사용하였다.88% by weight of Rose of Jericho ( Selaginella lepidophylla ) extract, 0.1% by weight of broccoli extract, and 0.05% by weight of Icelandic moss extract as active ingredients As a sunscreen for coat animals, a moisture mist was prepared. In addition to the above active ingredients, butylene glycol, saccharide isomerate, avocado fruit extract, coconut palm fruit extract, wormwood extract, propanediol, polyglyceryl-10 laurate, glycerin, jojoba seed extract, mexican chia seed extract, basil Seed Extract, Esculinta Lentils Seed Extract, Port Marigold Extract, Allantoin, Chamomile Flower Oil, Atlassida Wood Oil, 1,2-Hexanediol, Coconut Palm Tree, Fructan, Olive Extract, Setrol, Disodium EDIT A, Aloe Vera Leaf Extract, Dipropylene Glycol, Shea Butter, Olive Oil, Caprylic/Capric Triglyceride, Black Sesame Extract, Eye Horse Riding Extract, Thief's Wand Root Extract, Mulberry Bark Extract, Spanish Licorice Root Extract, Peony Root Extract, Mud Mushroom Extract, Angelica Root, Polyglyceryl-10 Stearate, Succulent Root Extract, Golden Extract, Squalane, Panthenol, Sodium Ascorbyl Phosphate, Hydrogenated Lecithin, Longi Pollen, Sodium Citrate, Citric Acid, avocado oil, coconut palm duck, jojoba seed oil, niacinamide, ceramide NP, cholesterol, biotin, folic acid, pyridoxine, phytosphingosine, cyanocobalamine, tocopherol, linoleic acid, fiboflavin, beta- A moisture mist was prepared to contain 0.15% by weight of carotene and thiamine HCL, and 2.7% by weight of distilled water. The extracts used water as a solvent.
비교예로, 증류수, DMDM 수화물, 글리콜 트리오토나이트, 프로필렌 글리콜(Propylene Glycol), 디카프릴레이트/디카프레이트를 포함하는 액상의 펫용 썬스크린을 준비하였다.As a comparative example, a liquid pet sunscreen containing distilled water, DMDM hydrate, glycol triotonite, propylene glycol, and dicaprylate/dicaprate was prepared.
실시예 2. 피부 자극에 대한 분석Example 2. Analysis of skin irritation
[실험동물][Experimental animals]
(1) 계통 및 종: NZW-Rabbit (Clean animal)(1) strain and species: NZW-Rabbit (Clean animal)
(2) 성별 및 연령: 암컷, 4개월령, (2) Gender and age: female, 4 months old;
(3) 약물투여 시 모델 동물의 체중: 2.2~2.5kg(3) The weight of the model animal at the time of drug administration: 2.2~2.5kg
[사육환경][Breeding Environment]
본 시험은 온도 20±3℃, 상대습도 50±20%, 환기횟수 10∼15회/시간, 조명주기 12시간, 조도 150∼300 Lux의 환경조건으로 설정된 호서대학교 안전성평가센터의 비설치류 동물사육실에서 실험동물을 사육하였다.This test was conducted in the non-rodent animal breeding room of the Hoseo University Safety Evaluation Center set under environmental conditions of temperature 20±3℃, relative humidity 50±20%, ventilation frequency 10-15 times/hour, illumination cycle 12 hours, and illuminance 150-300 Lux. Experimental animals were bred in
시험동물 입수 후 7일 이상 순화과정을 거치면서 체중감소 등의 이상이 없음을 확인한 후, 실험에 사용하였다.After obtaining the test animal, it was used for the experiment after confirming that there was no abnormality such as weight loss during the acclimatization process for at least 7 days.
본 실시예에서 사용한 시험물질의 투여량은 농림축산검역본부고시(제2016-22호, 2016.03.09) 및 OECD Acute Dermal Irritation/Corrosion (OECD 404, 2015. 07. 28)에서 권장하는 액체 투여량인 0.5㎖로 하였고, 시험물질 적용 24시간 전에 등 부위의 털을 동물용 전기 제모기를 사용하여 넓이 15×15cm가 되도록 제모하여, 건강하고 깨끗한 피부를 지닌 동물만을 선택한 후, 투여 당일 제모한 부위를 상하로 나누어 하측을 시험물질 투여구획, 상측을 대조구획으로 하였다. 투여구획과 대조구획은 다시 비찰과 부위와 찰과 부위로 구분하였으며, 같은 찰과 부위는 서로 대각선으로 분포하도록 하였다. 각 구역은 3×2cm의 넓이로 하였고 유성펜으로 구역의 경계를 표시하였다. 찰과 부위에는 주사기 바늘 끝을 이용하여 표피는 손상되나 진피는 손상되지 않을 정도의 손상을 입혔으며 출혈이 발생하지 않도록 하였다(표 1).The dosage of the test substance used in this example is the liquid dosage recommended by the Ministry of Agriculture, Food and Rural Affairs (No. 2016-22, 2016.03.09) and OECD Acute Dermal Irritation/Corrosion (OECD 404, 2015. 07. 28) 0.5 ml of phosphorus was used, and 24 hours before the test substance was applied, the hair on the back was removed to a width of 15 × 15 cm using an animal electric epilator. It was divided into upper and lower parts, and the lower part was used as a test substance administration compartment, and the upper part was used as a control compartment. The administration compartment and the control compartment were again divided into non-scratch and abrasion sites, and the same abrasion sites were distributed diagonally to each other. Each area was 3x2cm wide and the boundary of the area was marked with an oil-based pen. In the abrasion site, using the tip of a syringe needle, the epidermis was damaged but the dermis was not damaged enough to prevent bleeding (Table 1).
상측(대조구획)에는 멸균증류수(0.5㎖)를 도포한 3×2cm의 거즈를 적용하였고, 하측에는 시험물질(0.5㎖)을 도포한 거즈를 피부에 적용하였다. 거즈 위에는 시험물질의 유실을 막기 위해 비자극성 테이프(Tegarderm, 3M)로 덮은 후 의료용 반창고로 피부에 고정하였으며, 4시간 경과 후 제거하였다. 이때 투여부위에 시험결과에 영향을 끼치지 않는 범위에서 미온수의 멸균증류수를 사용하여 시험물질이 남아 있지 않도록 세척하였으며, 투여 당일을 Day 0으로 하였다.On the upper side (control compartment), 3×2 cm gauze coated with sterile distilled water (0.5 mL) was applied, and on the lower side, gauze coated with a test substance (0.5 mL) was applied to the skin. To prevent loss of the test substance, it was covered with non-irritating tape (Tegarderm, 3M) on the gauze and fixed to the skin with a medical bandage, and removed after 4 hours. At this time, the administration site was washed with sterile distilled water in lukewarm water in a range that did not affect the test results so that no test substance remained, and the day of administration was set as Day 0.
모든 투여동물에 대하여 투여 후부터 시험종료일까지 최소 1일 1회 이상 사망여부 및 임상증상을 개체별로 관찰하였다.For all treated animals, death and clinical symptoms were observed individually at least once a day from the time of administration to the end of the test.
(1) 체중측정(1) Weighing
체중은 투여 전 1회, 투여 당일, 투여 개시 후 1, 3일째에 측정하였다.Body weight was measured once before administration, on the day of administration, and on days 1 and 3 after initiation of administration.
그 결과, 시험기간 동안 사망동물은 관찰되지 않았고, 시험기간 동안 시험물질에 의한 특이적인 증상은 관찰되지 않았으며, 체중 변화도 나타나지 않았다(표 2).As a result, no dead animals were observed during the test period, no specific symptoms by the test substance were observed during the test period, and no change in body weight was observed (Table 2).
(2) 피부반응의 관찰(2) Observation of skin reaction
시험물질 적용 후 24, 48, 72 시간째에 모든 동물의 피부 홍반, 가피 및 부종 발생유무를 평가하였다. 적용부위 피부 병변에 대한 평가는 표 3에 개시한 '피부반응의 평가 등급표'에 따라 관찰하고 평가하였다.At 24, 48, and 72 hours after application of the test substance, the presence or absence of skin erythema, crusting, and edema of all animals was evaluated. The evaluation of the skin lesions at the application site was observed and evaluated according to the 'Evaluation Rating Table for Skin Reaction' disclosed in Table 3.
그 결과, 멸균증류수 적용 비찰과 부위와 찰과 부위에서는 피부 반응이 관찰되지 않았다. 본 발명의 모이스처 미스트 적용 비찰과 부위에서는 72시간 동안 홍반과 부종이 관찰되지 않았으며, 찰과 부위에서는 시험물질 노출 후 24시간 째에 2 마리에서 아주 가벼운 홍반이 관찰되었으나, 48시간째부터는 모든 개체에서 홍반이 관찰되지 않았다. 찰과 부위에서 부종은 모든 개체에서 관찰되지 않았다(도 1).As a result, no skin reaction was observed in the non-abrasive and abrasive regions where sterile distilled water was applied. Erythema and edema were not observed for 72 hours at the non-abrasion site applied with the moisture mist of the present invention, and very mild erythema was observed in 2 animals 24 hours after exposure to the test substance at the abrasion site, but from 48 hours on, all subjects No erythema was observed in Edema at the abrasion site was not observed in all subjects (FIG. 1).
비교예의 펫 썬스크린 적용 비찰과 부위에서는 72시간 동안 홍반과 부종이 관찰되지 않았으나, 찰과 부위에서는 시험물질 노출 후 24시간째에 2 마리에서 홍반이 관찰되었으며, 이 중 1마리는 72시간째까지 분명한 홍반이 관찰되었고, 4일째에는 홍반이 관찰되지 않았으며, 나머지 1마리에서는 48시간째부터 홍반이 관찰되지 않았다. 또한, 시험물질 4시간 노출 직후 1마리에서 부종이 관찰되었지만 24시간째부터 72시간 째까지 모든 개체에서 부종은 관찰되지 안았다(도 2).Erythema and edema were not observed for 72 hours at the non-abrasion site applied with the pet sunscreen of the comparative example, but erythema was observed in 2 animals 24 hours after exposure to the test substance in the abrasion site, and one of them was observed up to 72 hours. Clear erythema was observed, and no erythema was observed on the 4th day, and no erythema was observed from the 48th hour on the other animal. In addition, edema was observed in one animal immediately after exposure to the test substance for 4 hours, but no edema was observed in all subjects from 24 hours to 72 hours ( FIG. 2 ).
(3) 피부 자극성 판정(3) Determination of skin irritation
시험물질에 대한 피부 자극성 판정은 일차 피부자극 지수를 이용하여 표 4에 개시한 바와 같이 '피부자극성 판정 지표'에 의해 구분하여 평가하였다. 일차 피부자극 지수는 각 관찰 시기별로 모든 투여 동물의 홍반 및 부종 점수를 더해서 그 평균값으로 하였다.The skin irritation determination for the test substance was evaluated by using the primary skin irritation index, as shown in Table 4, by 'skin irritation determination index'. The primary skin irritation index was taken as the average value by adding the erythema and edema scores of all treated animals for each observation period.
본 실시예 2에서는 반려견용 자외선 차단 미스트의 피부자극성 또는 부식성의 정도를 조사하기 위하여, 암컷 백색 토끼 피부에 시험물질을 4시간 동안 적용한 후 72시간 관찰하면서 시험물질의 피부자극에 대한 정도를 확인하였다. In this Example 2, in order to investigate the degree of skin irritation or corrosiveness of the sunscreen mist for dogs, the test material was applied to the skin of a female white rabbit for 4 hours and then observed for 72 hours, and the degree of skin irritation of the test material was confirmed. .
그 결과, 본 발명에 따른 모이스처 미스트와 비교예인 펫 썬스크린 적용 후 72시간 동안 관찰된 일차 피부자극 지수는(P.I.I.)는 각각 0.167과 0.584로 산출되어 본 발명의 모이스쳐 미스트와 펫 썬스크린은 비자극성 물질로 판단되었다.As a result, the primary skin irritation index (P.I.I.) observed for 72 hours after application of the moisture mist according to the present invention and the comparative example pet sunscreen was calculated as 0.167 and 0.584, respectively, so the moisture mist and pet sunscreen of the present invention were non-irritating. considered to be material.
실시예 3. 자외선 차단 성능 시험Example 3. UV protection performance test
본 실시예 3에서는 본 발명에 따른 모이스쳐 미스트와 비교예인 펫 썬스크린에 대한 자외선 차단 성능지수 SPF(Sun Protection Factor) 지수를 확인하였다. In Example 3, the UV protection performance index SPF (Sun Protection Factor) index for the moisturizing mist according to the present invention and the pet sunscreen as a comparative example was confirmed.
MPF(Monochromatic Protection Factor)은 자외선 파장에 대한 보호 능력으로, SPF 지수와 동일 능력을 의미하는 것이며, MPF 지수가 높을수록 자외선 차단 지수가 높다는 것을 의미한다. 또한, SPF 지수(MPF 지수) 2는 50% 자외선 차단하는 것이며, 피모동물의 경우, 50% 자외선 차단만으로도 안전한 것으로 알려져 있어, 50% 자외선 차단을 기준으로 하였으며, 본 실시예 3에서 측정한 결과, UVB 영역인 290~320nm 파장범위에서의 평균 MPF 지수가 2.3~2.5 수준으로 확인되어 50% 자외선 차단효과가 있는 것으로 판단하였다.MPF (Monochromatic Protection Factor) is the ability to protect against ultraviolet wavelengths, meaning the same ability as the SPF index, and the higher the MPF index, the higher the UV protection index. In addition, SPF index (MPF index) 2 is to block 50% UV rays, and in the case of coat animals, it is known that only 50% UV protection is safe, so 50% UV protection was used as a standard, and the results measured in Example 3, The average MPF index in the wavelength range of 290-320 nm, which is the UVB region, was found to be 2.3-2.5, and it was determined that there was a 50% UV-blocking effect.
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200162901 | 2020-11-27 | ||
KR20200162901 | 2020-11-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220074809A true KR20220074809A (en) | 2022-06-03 |
KR102636498B1 KR102636498B1 (en) | 2024-02-15 |
Family
ID=81983354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210167486A KR102636498B1 (en) | 2020-11-27 | 2021-11-29 | UV block for animal with skin and fur comprising mixture of plant extract as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102636498B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008074816A (en) * | 2006-09-25 | 2008-04-03 | Oriza Yuka Kk | In vivo antioxidant |
KR20150145947A (en) * | 2014-06-20 | 2015-12-31 | 주식회사 더마랩 | Cosmetic composition for ultraviolet-proof containing the extract of Uncaria tomentosa, Cetraria islandica and Euterpe oleracea |
KR20190107856A (en) * | 2018-03-13 | 2019-09-23 | 코스맥스 주식회사 | Cosmetic Composition for UV and Bule-light Protection |
-
2021
- 2021-11-29 KR KR1020210167486A patent/KR102636498B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008074816A (en) * | 2006-09-25 | 2008-04-03 | Oriza Yuka Kk | In vivo antioxidant |
KR20150145947A (en) * | 2014-06-20 | 2015-12-31 | 주식회사 더마랩 | Cosmetic composition for ultraviolet-proof containing the extract of Uncaria tomentosa, Cetraria islandica and Euterpe oleracea |
KR20190107856A (en) * | 2018-03-13 | 2019-09-23 | 코스맥스 주식회사 | Cosmetic Composition for UV and Bule-light Protection |
Also Published As
Publication number | Publication date |
---|---|
KR102636498B1 (en) | 2024-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108653090A (en) | A kind of antiallergic composition | |
US20170246106A1 (en) | Methods and compositions for maintaining and improving the health of skin | |
KR102083294B1 (en) | A composition for skin reproduction containing extracts of abeliophyllum distichum and extract thereof having skin reproduction effect | |
CN1703231A (en) | Use of purslane to treat facial wrinkles | |
KR20200113600A (en) | Composition for hairloss and scalp care | |
CA2139253C (en) | Skin external agent | |
KR102026399B1 (en) | Cosmetic composition for skin Humectant comprising Opuntia Ficus-Indica fruit extract and mixed compound of panthenol, hyaluronic acid and betaine | |
KR20180118409A (en) | Nutrition Cream Containing Ergothioneine and Its Manufacturing Method | |
KR101418366B1 (en) | Composition containing bee venom and propolis for preventing or treating acne | |
KR101857282B1 (en) | Cosmetic composition comprising the extract of ishige okamurae | |
CN107049881A (en) | A kind of dog cat health fragrance involves its preparation method | |
KR102636498B1 (en) | UV block for animal with skin and fur comprising mixture of plant extract as effective component | |
DE60119210T2 (en) | New actif, as well as their compositions, their use in cosmetics, dermocosmetics, dermopharmacy, pharmacy and nonwovens | |
DE102007024679B4 (en) | Use of cosmetically active agents to protect FGF-2 | |
KR20110030187A (en) | (a cosmetic composition for skin miosture containing mixing extract of sparassis crispa, agaricus blazeii and polyporus umbellatus | |
DE60312988T2 (en) | USE OF A CHRYSANTHELLUM INDICUM EXTRACT FOR THE TREATMENT OF THE ACNE ROSACEA | |
KR20140143644A (en) | omposition for skin external application for improvement of atopic dermatitis using essential oil from chamaecyparis obtusa | |
KR101250386B1 (en) | Cosmetic composition containing mixed sprout extracts having the calming effect for skins | |
EP3658112B1 (en) | Active substance combinations of n-(4-amino-2-methylquinoline-6-yl)-2-((4-ethylphenoxy)methyl)benzamide and one or more cosmetically or dermatologically acceptable preservatives and/or preservative auxiliaries | |
KR101436819B1 (en) | Cosmetic composition for moisturing, soothing skin and improving acne | |
KR100884258B1 (en) | Pack cosmetic composition comprising herbal extracts for pore-minimizing and sebum-control | |
KR100829720B1 (en) | Astringent Cosmetic Composition Comprising the Extract from the Fruit of Rubus coreanum as Active Ingredient | |
EP1131101B1 (en) | Khellin preparation and the use thereof for topical therapy | |
CN103830303A (en) | Composition for bedsore prevention | |
KR102503480B1 (en) | Herb pack powder and bath preparation composition for pet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |